StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Koselugo (selumetinib) — Worldwide YoY CER by Quarter

Koselugo (selumetinib) — Worldwide YoY CER (%) (%)

QuarterlyAnnual

AstraZeneca Koselugo (selumetinib) — Worldwide YoY CER: 27.0% in Q2 2026, up 9.0 pts from a year earlier.

Latest, Q2 2026
27.0%
Period ended Jun 30, 2026
Change on a year earlier
+9.0 pts
18.0% in Q2 2025
History
17 quarters
Since Q4 2021
Sources
17
Documents cited below

Where the Q2 2026 figure comes from

“|| Koselugo | 177 | | 29 | | 27 | | 52 | | - | | 54 | | 51 | | 45 | | 50 | | 34 | | 27 | | 21 | | 78 | | 90”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Product Sales Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedKoselugo (selumetinib) — Worldwide YoY CER (%) (%)Year on yearSource
Q2 2026Jun 30, 202627.0%+9.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 202615.0%+7.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025-4.0%-101.0 ptsForm 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 202579.0%+40.0 ptsForm 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 202518.0%-27.0 ptsForm 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 20258.0%-74.0 ptsForm 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 202497.0%+49.0 ptsForm 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 202439.0%-42.0 ptsForm 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 202445.0%+15.0 ptsForm 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 202482.0%–Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 202348.0%-29.0 ptsForm 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 202381.0%0.0 ptsForm 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 202330.0%–Form 6-K FY2023Q2 Earnings Release ↗
Q4 2022Dec 31, 202277.0%-17.0 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 202281.0%–Form 6-K FY2022Q3 Earnings Release ↗
Q1 2022Mar 31, 202285.0%–Form 6-K FY2022Q1 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Koselugo (selumetinib) — Worldwide YoY CER (%), quarterly Q4 2021–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-koselugo-world-cer-yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.